Insiders · FUSN

FUSN insider transactions

Fusion Pharmaceuticals Inc. (FUSN) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

FUSN insiders

Everyone who has filed a Form 3, 4, 5 or 144 at Fusion Pharmaceuticals Inc., latest first. Follow anyone to get their next filing.

• Teresa Marie BitettiDirector, since October 2023
• Steven GannonDirector+$187K
• John ValliantChief Executive Officer, Director-$1.6M
• Pablo J CagnoniDirector
• Philina LeeDirector, since February 2021
• Mohit RawatPresident & CBO, since September 2021
• John J CrowleyChief Financial Officer
• David D. MeekDirector, since October 2023
• Dmitri BobilevChief Medical Officer, since November 2022
• Jeremy BenderDirector, since October 2023
• Barbara Gayle DuncanDirector
• Eric BurakChief Technology Officer
• Christopher P LeamonChief Scientific Officer, since November 2021
• Donald A BergstromDirector, since April 2021
• Chau Quang KhuongDirector
• Heather PrestonDirector
• James J O'LearyOfficer

Recent Form 3, 4, and 5 filings for FUSN

• 890d
  SEC Form 4 filed by Bitetti Teresa Marie

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 890d
  Gannon Steven returned 56,400 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 890d
  Valliant John returned 318,147 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 890d
  SEC Form 4 filed by Cagnoni Pablo J

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 890d
  SEC Form 4 filed by Lee Philina

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 890d
  Rawat Mohit returned 21,699 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 890d
  Crowley John J returned 10,410 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 890d
  SEC Form 4 filed by Meek David D.

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 890d
  SEC Form 4 filed by Bobilev Dmitri

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 890d
  SEC Form 4 filed by Bender Jeremy

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 890d
  SEC Form 4 filed by Duncan Barbara Gayle

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 890d
  Burak Eric returned 38,490 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 890d
  Leamon Christopher P returned 11,957 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 890d
  SEC Form 4 filed by Bergstrom Donald A

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1041d
  Leamon Christopher P was granted 11,957 shares (SEC Form 4)

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1041d
  SEC Form 4 filed by Crowley John J

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1041d
  SEC Form 4 filed by Burak Eric

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1041d
  Rawat Mohit was granted 12,843 shares (SEC Form 4)

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1041d
  SEC Form 4 filed by Bobilev Dmitri

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1041d
  SEC Form 4 filed by Valliant John

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1122d
  SEC Form 4 filed by Meek David D.

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1122d
  SEC Form 4 filed by Bitetti Teresa Marie

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1122d
  SEC Form 4 filed by Bender Jeremy

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1122d
  SEC Form 3 filed by new insider Bitetti Teresa Marie

  3 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1122d
  SEC Form 3 filed by new insider Meek David D.

  3 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1122d
  SEC Form 3 filed by new insider Bender Jeremy

  3 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1246d
  SEC Form 4 filed by Preston Heather

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1246d
  SEC Form 4 filed by Lee Philina

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1246d
  SEC Form 4 filed by Khuong Chau Quang

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1246d
  SEC Form 4 filed by Gannon Steven

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1246d
  SEC Form 4 filed by Duncan Barbara Gayle

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1246d
  SEC Form 4 filed by Cagnoni Pablo J

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1246d
  SEC Form 4 filed by Bergstrom Donald A

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1402d
  SEC Form 4 filed by Valliant John

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1402d
  SEC Form 4 filed by Rawat Mohit

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1402d
  SEC Form 4 filed by Leamon Christopher P

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1402d
  SEC Form 4 filed by Crowley John J

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1402d
  SEC Form 4 filed by Burak Eric

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1458d
  SEC Form 4: Khuong Chau Quang was granted 42,093 shares

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1465d
  SEC Form 4 filed by Bobilev Dmitri

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1465d
  SEC Form 3 filed by new insider Bobilev Dmitri

  3 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1553d
  SEC Form 4: Gannon Steven bought $90,132 worth of shares (44,400 units at $2.03), increasing direct ownership by 370% to 56,400 units

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1603d
  SEC Form 4 filed by Preston Heather

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1603d
  SEC Form 4 filed by Lee Philina

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1603d
  SEC Form 4 filed by Khuong Chau Quang

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1603d
  SEC Form 4 filed by Gannon Steven

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1603d
  SEC Form 4 filed by Duncan Barbara Gayle

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1603d
  SEC Form 4 filed by Cagnoni Pablo J

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1603d
  SEC Form 4 filed by Bergstrom Donald A

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1659d
  SEC Form 4: Valliant John sold $52,511 worth of shares (8,694 units at $6.04) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 318,147 units

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1664d
  SEC Form 4: Valliant John sold $7,751 worth of shares (1,289 units at $6.01) as part of a pre-agreed trading plan, decreasing direct ownership by 0.39% to 326,841 units

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1673d
  SEC Form 4: Valliant John sold $225,654 worth of shares (32,849 units at $6.87) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 328,130 units

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1678d
  SEC Form 4: Valliant John sold $16,457 worth of shares (2,181 units at $7.55) as part of a pre-agreed trading plan, decreasing direct ownership by 0.60% to 360,979 units

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1681d
  SEC Form 4: Valliant John sold $29,324 worth of shares (3,800 units at $7.72) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 363,160 units

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1685d
  SEC Form 4: Valliant John sold $2,256 worth of shares (300 units at $7.52) as part of a pre-agreed trading plan, decreasing direct ownership by 0.08% to 366,960 units

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1688d
  SEC Form 4: Valliant John sold $77,694 worth of shares (10,300 units at $7.54) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 367,260 units

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1693d
  SEC Form 4: Valliant John sold $36,092 worth of shares (4,800 units at $7.52) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 377,560 units

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1696d
  SEC Form 4: Valliant John sold $27,126 worth of shares (3,604 units at $7.53) as part of a pre-agreed trading plan, decreasing direct ownership by 0.93% to 382,360 units

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1701d
  SEC Form 4: Valliant John sold $10,459 worth of shares (1,500 units at $6.97) as part of a pre-agreed trading plan, decreasing direct ownership by 0.39% to 385,964 units

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1703d
  SEC Form 4: Valliant John sold $19,832 worth of shares (2,822 units at $7.03) as part of a pre-agreed trading plan, decreasing direct ownership by 0.72% to 387,464 units

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)